ANI Pharmaceuticals (ANIP) GC has 2,466 shares withheld for taxes on RSU vesting

Rhea-AI Filing Summary

ANI Pharmaceuticals reported that executive Meredith Cook, Sr. VP, General Counsel & Secretary, had 2,466 shares of common stock withheld on July 18, 2026 to cover tax obligations, at $79.20 per share. The withholding related to the vesting of 4,820 restricted shares. Following this transaction, Cook directly holds 74,924 shares of ANI Pharmaceuticals common stock.

Insider Trade Summary

Net Seller: 2,466 shares

Net Sell 1 txn

Insider Cook Meredith

Role SR. VP, GENERAL COUNSEL & SEC.

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	2,466	$79.20	$195K

Holdings After Transaction: Common Stock — 74,924 shares (Direct)

Footnotes (1)

1. F1. Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported on July 20, 2022.

Key Figures

Shares withheld for taxes: 2,466 shares Withholding price: $79.20 per share Shares after transaction: 74,924 shares +1 more

4 metrics

Shares withheld for taxes 2,466 shares Common stock withheld on July 18, 2026 for tax obligations

Withholding price $79.20 per share Value used for the 2,466 withheld shares

Shares after transaction 74,924 shares Direct common stock holdings of Meredith Cook following the withholding

Restricted shares vested 4,820 shares Restricted stock vesting that triggered the tax withholding

Key Terms

tax-withholding disposition, restricted stock, Rule 16(b)-3

3 terms

tax-withholding disposition financial

"Reported as a tax-withholding disposition of 2,466 shares of common stock"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

restricted stock financial

"in connection with the vesting of 4,820 shares of restricted stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Rule 16(b)-3 regulatory

"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/21/2026 - 04:32 PM Accepted by SEC EDGAR 07/21/2026 - 04:32 PM Learn about SEC filing dates

FAQ

What insider transaction did ANI Pharmaceuticals (ANIP) report for Meredith Cook?

ANI Pharmaceuticals reported a tax-withholding disposition for Meredith Cook, where 2,466 common shares were withheld at $79.20 per share on July 18, 2026. The shares were used to satisfy tax obligations arising from the vesting of 4,820 restricted shares.

Were Meredith Cook’s ANI Pharmaceuticals (ANIP) shares sold in the open market?

No. The 2,466 shares were withheld for tax purposes by the issuer, not sold in an open-market transaction. The filing notes this withholding is exempt under Rule 16(b)-3 and is tied to the vesting of restricted stock previously granted.

How many ANI Pharmaceuticals (ANIP) shares does Meredith Cook hold after this Form 4 transaction?

After the reported tax-withholding event, Meredith Cook directly holds 74,924 shares of ANI Pharmaceuticals common stock. This figure reflects her position following the withholding of 2,466 shares connected to the vesting of restricted stock on July 18, 2026.

What triggered the tax-withholding share disposition at ANI Pharmaceuticals (ANIP)?

The disposition was triggered by the vesting of 4,820 restricted shares of ANI Pharmaceuticals common stock. These restricted shares were granted on July 20, 2022, and the company withheld 2,466 shares to cover applicable tax obligations at vesting.

Was the ANI Pharmaceuticals (ANIP) Form 4 transaction under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, and the footnote describes the transaction solely as shares withheld for tax purposes. There is no indication that this disposition occurred under a pre-arranged trading plan.

What price was used for the ANI Pharmaceuticals (ANIP) tax-withholding shares?

The 2,466 shares withheld for tax purposes were valued at $79.20 per share. This per-share price is used to determine the value of shares applied toward Cook’s tax liabilities arising from the vesting of 4,820 restricted shares of common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cook Meredith

(Last) (First) (Middle)

C/O ANI PHARMACEUTICALS, INC.

104 CARNEGIE CENTER, SUITE 300

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ANI PHARMACEUTICALS INC [ ANIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SR. VP, GENERAL COUNSEL & SEC.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/18/2026		F(1)		2,466	D	$79.2	74,924	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported on July 20, 2022.

Remarks:

	/s/ Meredith W. Cook	07/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)